Department of Clinical Pharmacology and Toxicology, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.
DZHK Standort Hamburg, Kiel, Lübeck, Germany.
Cells. 2024 Feb 11;13(4):333. doi: 10.3390/cells13040333.
The dual leucine zipper kinase (DLK) alias mitogen-activated protein 3 kinase 12 (MAP3K12) has gained much attention in recent years. DLK belongs to the mixed lineage kinases, characterized by homology to serine/threonine and tyrosine kinase, but exerts serine/threonine kinase activity. DLK has been implicated in many diseases, including several neurodegenerative diseases, glaucoma, and diabetes mellitus. As a MAP3K, it is generally assumed that DLK becomes phosphorylated and activated by upstream signals and phosphorylates and activates itself, the downstream serine/threonine MAP2K, and, ultimately, MAPK. In addition, other mechanisms such as protein-protein interactions, proteasomal degradation, dephosphorylation by various phosphatases, palmitoylation, and subcellular localization have been shown to be involved in the regulation of DLK activity or its fine-tuning. In the present review, the diverse mechanisms regulating DLK activity will be summarized to provide better insights into DLK action and, possibly, new targets to modulate DLK function.
双亮氨酸拉链激酶 (DLK) 又名丝裂原活化蛋白激酶 3 激酶 12 (MAP3K12),近年来受到了广泛关注。DLK 属于混合谱系激酶,其特征为丝氨酸/苏氨酸和酪氨酸激酶同源性,但具有丝氨酸/苏氨酸激酶活性。DLK 与许多疾病有关,包括几种神经退行性疾病、青光眼和糖尿病。作为一种 MAP3K,人们普遍认为 DLK 通过上游信号被磷酸化和激活,并磷酸化和激活自身、下游丝氨酸/苏氨酸 MAP2K,最终激活 MAPK。此外,还显示出其他机制,如蛋白质-蛋白质相互作用、蛋白酶体降解、各种磷酸酶的去磷酸化、棕榈酰化和亚细胞定位,参与了 DLK 活性的调节或其微调。在本综述中,将总结调节 DLK 活性的多种机制,以便更好地了解 DLK 的作用,并可能为调节 DLK 功能提供新的靶点。